Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rubenken
    Junior Member
    • Feb 2009
    • 7

    #1

    Ion Torrent versus 454 FLX Junior

    Any thoughts on whether either system is favorable for diagnostic applications and which might be favored?
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    Junior has the jump to get in. Cost of ~$2K/run (corrections welcome) in reagents means it will probably still be necessary to multiplex samples for many applications. Longer read length will be valuable -- when needed.

    Ion Torrent isn't here yet. I think the upfront cost is about 1/2 ($100K vs. $200K), though I've seen different claims for Junior. Sample prep gear for both may be similar, which would narrow the relative (but not absolute) cost differential. Ion Torrent will be similar number of reads but shorter reads at 1/4 the run cost (right?) -- if it comes in as advertised.

    I'd give Ion Torrent the edge. If the chemistry can be pushed to 454-like read lengths without upping the cost (likely, given that most of the chemistry cost is in the chip), then 454 is is big trouble.

    See also my blog posts Worse Could Be Better and http://omicsomics.blogspot.com/2010/08/Who Has The Lead in 1K Genome Race?

    Comment

    • henry.wood
      Member
      • Apr 2010
      • 63

      #3
      I don't know exactly what you are planning, but some colleagues of mine have been using an illumina for diagnostic sequencing. They do multiplexed sequencing of long PCR products. If you want to know more, have a look at http://www.ncbi.nlm.nih.gov/pubmed/20127978

      Comment

      • SrScientist
        Junior Member
        • Oct 2010
        • 5

        #4
        Life Tech mentions that Ion Torrent instrument and run will be even cheaper than Junior. And if I have a look into the actual "specs", I see no reason to purchase a Junior.

        Comment

        • Jacky76
          Junior Member
          • Jan 2011
          • 4

          #5
          What's better? depends on what you will do

          I'm not sure what you are planning, there are many kinds of diagnostic sequencing and most of them need longer read length in my experience. I guess many applications are replacing Sanger, and most of amplicons have loger than 300bp something. If you want to look into the mutations like insertion, deletion, you will have problem with the short read length. Furthermore, longer reads means better ability for haplotyping. Many of diagnostic sequencings need to see haplotypes. But if you think 100bp is enough for your application, you will take advantage with IT. But the concern here is their performance was not yet validated than GS Junior. And it is the biggest challenge at improving sequencing technology that lengthening the read length. So I don't think Ion Torrent can have enough reads soon. GS Junior has been being tested so far for diagnostic purpose by MDs, and has been getting good evaluation. But there is still concern on it's result. GS Junior still has difficulty on reading homopolymeric regions.

          Comment

          • dc3000
            Junior Member
            • Nov 2010
            • 7

            #6
            Any updates here, especially for using the Ion Torrent for amplicon sequencing (16S, etc.)?

            Comment

            • colindaven
              Senior Member
              • Oct 2008
              • 417

              #7
              Try this, if you haven't already:

              Article (Loman2012) Loman, N. J.; Misra, R. V.; Dallman, T. J.; Constantinidou, C.; Gharbia, S. E.; Wain, J. & Pallen, M. J. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol, Centre for Systems Biology, University of Birmingham, Birmingham, UK., 2012

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                by SEQadmin2



                Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                ...
                10-14-2026, 09:55 AM
              • SEQadmin2
                New Genomics Technologies Take Aim at Long-Standing Limits
                by SEQadmin2


                Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                ...
                09-28-2026, 10:25 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 11:13 AM
              0 responses
              17 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, Yesterday, 10:48 AM
              0 responses
              18 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-15-2026, 10:52 AM
              0 responses
              36 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-14-2026, 05:39 AM
              0 responses
              42 views
              0 reactions
              Last Post SEQadmin2  
              Working...